Publications by authors named "Steven W Lane"

Claim this Profile
B
Bcl-xL inhibition potentiates interferon-induced apoptosis in MPN stem cells.
Megan J Bywater, Rohit Haldar, Yashaswini Janardhanan, Emily Cooper, Leanne Cooper, Steven W Lane

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding RNA modifications to unlock new treatments for AML.
Steven W Lane, Megan Bywater

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZRSR2 loss causes aberrant splicing in JAK2-driven myeloproliferative neoplasm but is not sufficient to drive disease progression.
Ranran Zhang, Jasmin Straube, Yashaswini Janardhanan, Rohit Haldar, Leanne Cooper, Steven W Lane

Hemasphere· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention, diagnosis and management of myeloproliferative neoplasms: an introduction to a review series.
Yin Yuan, Steven W Lane

Haematologica· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.
Harry J Iland, John Reynolds, Alan V Boddy, Hayley B Schultz, Liane Khoo, Steven W Lane

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying disease-modifying potential in myelofibrosis clinical trials.
David M Ross, Steven W Lane, Claire N Harrison

Blood· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autophagy prevents graft failure during murine graft-versus-host disease.
Katie E Lineburg, Lucie Leveque-El Mouttie, Christopher R Hunter, Laetitia Le Texier, Crystal McGirr, Steven W Lane

Blood Adv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival for the fittest: guadecitabine in rel/ref AML.
Joshua Sheehy, Steven W Lane

Blood Adv· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imetelstat-mediated alterations in fatty acid metabolism to induce ferroptosis as a therapeutic strategy for acute myeloid leukemia.
Claudia Bruedigam, Amy H Porter, Axia Song, Gerjanne Vroeg In de Wei, Thomas Stoll, Steven W Lane

Nat Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.
Nuria Tubío-Santamaría, Ashok Kumar Jayavelu, Tina M Schnoeder, Theresa Eifert, Chen-Jen Hsu, Steven W Lane

Mol Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clearing the way for new therapies in clonal hematopoiesis.
Victoria Y Ling, Steven W Lane

Blood Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell fate determinant Llgl1 is required for propagation of acute myeloid leukemia.
Theresa Eifert, Chen-Jen Hsu, Alicia L Becker, Sarah Graessle, Arik Horne, Steven W Lane

Leukemia· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide transcription factor-binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs.
Shruthi Subramanian, Julie A I Thoms, Yizhou Huang, Paola Cornejo-Páramo, Forrest C Koch, Steven W Lane

Blood· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The TRIM31 paradox: an unexpected benefit for leukemia stem cells.
Jasmin Straube, Steven W Lane

Haematologica· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation.
Harry J Iland, Nigel Russell, Richard Dillon, Andre C Schuh, Aditya Tedjaseputra, Steven W Lane

Blood Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shelter from the cytokine storm in myelofibrosis.
Steven W Lane

Blood· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemia.
Jasmin Straube, Theresa Eifert, Therese Vu, Yashaswini Janardhanan, Rohit Haldar, Steven W Lane

Leukemia· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic drivers dictate immune control of acute myeloid leukemia.
Rebecca J Austin, Jasmin Straube, Rohit Halder, Yashaswini Janardhanan, Claudia Bruedigam, Steven W Lane

Nat Commun· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
t(15;17) in acute promyelocytc leukemia.
Victoria Y Ling, Steven W Lane

Haematologica· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia.
Victoria Y Ling, Jasmin Straube, William Godfrey, Rohit Haldar, Yashaswini Janardhanan, Steven W Lane

Leukemia· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depletion of exhausted alloreactive T cells enables targeting of stem-like memory T cells to generate tumor-specific immunity.
Simone A Minnie, Olivia G Waltner, Kathleen S Ensbey, Nicole S Nemychenkov, Christine R Schmidt, Steven W Lane

Sci Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paving the way to improve therapy for Myeloproliferative Neoplasms.
Megan Bywater, Steven W Lane

Nat Commun· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML.
Jessica M Salmon, Izabela Todorovski, Kym L Stanley, Claudia Bruedigam, Conor J Kearney, Steven W Lane

Cancer Discov· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.
Xian-Yang Li, Indrajit Das, Ailin Lepletier, Venkateswar Addala, Tobias Bald, Steven W Lane

J Clin Invest· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLCG1 is required for AML1-ETO leukemia stem cell self-renewal.
Tina M Schnoeder, Adrian Schwarzer, Ashok Kumar Jayavelu, Chen-Jen Hsu, Joanna Kirkpatrick, Steven W Lane

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis